HSDT
Income statement / Annual
Last year (2024), Helius Medical Technologies, Inc.'s total revenue was $520,000.00,
a decrease of 19.25% from the previous year.
In 2024, Helius Medical Technologies, Inc.'s net income was -$11.74 M.
See Helius Medical Technologies, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$520,000.00 |
$644,000.00 |
$787,000.00 |
$522,000.00 |
$661,000.00 |
$1.50 M |
$478,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$582,000.00
|
$583,000.00
|
$463,000.00
|
$298,000.00
|
$751,000.00
|
$910,000.00
|
$59,000.00
|
$17,000.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$62,000.00
|
$61,000.00
|
$324,000.00
|
$224,000.00
|
-$90,000.00
|
$586,000.00
|
$419,000.00
|
-$17,000.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
-0.12
|
0.09
|
0.41
|
0.43
|
-0.14
|
0.39
|
0.88
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.66 M
|
$2.94 M
|
$4.26 M
|
$5.99 M
|
$4.58 M
|
$8.06 M
|
$9.94 M
|
$14.39 M
|
$3.65 M
|
$4.50 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.12 M
|
$9.27 M
|
$10.64 M
|
$12.18 M
|
$9.40 M
|
$16.52 M
|
$17.16 M
|
$8.45 M
|
$5.67 M
|
$5.31 M
|
| Other Expenses |
$64,000.00
|
$276,000.00
|
$938,000.00
|
$200,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.84 M
|
$12.49 M
|
$15.84 M
|
$18.37 M
|
$13.99 M
|
$24.58 M
|
$27.09 M
|
$22.84 M
|
$9.32 M
|
$9.81 M
|
| Cost And Expenses |
$14.42 M
|
$13.07 M
|
$16.30 M
|
$18.66 M
|
-$14.74 M
|
-$25.49 M
|
-$27.15 M
|
-$22.85 M
|
-$9.32 M
|
-$9.81 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$20,074.00
|
| Interest Expense |
$0.00
|
$0.00
|
$834,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$46,920.00
|
$176,488.00
|
| Depreciation & Amortization |
$60,000.00
|
$162,000.00
|
$255,000.00
|
$312,000.00
|
$482,000.00
|
$191,000.00
|
$59,000.00
|
$17,000.00
|
$0.00
|
$0.00
|
| EBITDA |
-$13.80 M |
-$12.11 M |
-$14.50 M |
-$17.82 M |
-$13.65 M |
-$9.59 M |
-$28.56 M |
-$28.01 M |
-$6.83 M |
-$9.66 M |
| EBITDA Ratio |
-26.54
|
-18.8
|
-18.43
|
-34.14
|
-20.65
|
-6.41
|
-59.76
|
0
|
0
|
0
|
| Operating Income Ratio |
-26.74
|
-19.3
|
-19.72
|
-34.75
|
-21.3
|
-16.04
|
-55.81
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.16 M
|
$3.58 M
|
$1.44 M
|
$10,000.00
|
-$54,000.00
|
$14.22 M
|
-$1.95 M
|
-$5.17 M
|
$2.44 M
|
-$29,873.00
|
| Income Before Tax |
-$11.74 M
|
-$8.85 M
|
-$14.07 M
|
-$18.13 M
|
-$14.13 M
|
-$9.78 M
|
-$28.62 M
|
-$28.02 M
|
-$6.88 M
|
-$9.84 M
|
| Income Before Tax Ratio |
-22.58
|
-13.74
|
-17.88
|
-34.74
|
-21.38
|
-6.54
|
-59.88
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.74 M
|
-$8.85 M
|
-$14.07 M
|
-$18.13 M
|
-$14.13 M
|
-$9.78 M
|
-$28.62 M
|
-$28.02 M
|
-$6.88 M
|
-$9.84 M
|
| Net Income Ratio |
-22.58
|
-13.74
|
-17.88
|
-34.74
|
-21.38
|
-6.54
|
-59.88
|
0
|
0
|
0
|
| EPS |
-4.33 |
-14.56 |
-52.13 |
-369.02 |
-589.86 |
-649.56 |
-2198.39 |
-2632.1 |
-905.19 |
-1508.99 |
| EPS Diluted |
-4.33 |
-14.56 |
-52.13 |
-369.02 |
-589.86 |
-649.56 |
-2198.39 |
-2632.1 |
-898.39 |
-1508.99 |
| Weighted Average Shares Out |
$2.71 M
|
$1.22 M
|
$539,886.00
|
$98,270.00
|
$47,910.00
|
$30,116.00
|
$26,040.00
|
$21,294.00
|
$15,205.16
|
$13,039.64
|
| Weighted Average Shares Out Diluted |
$2.71 M
|
$1.22 M
|
$539,886.00
|
$98,270.00
|
$47,910.00
|
$30,116.00
|
$26,040.00
|
$21,294.00
|
$15,320.35
|
$13,039.64
|
| Link |
|
|
|
|
|
|
|
|
|
|
